Ignite Creation Date:
2024-05-06 @ 3:00 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04493242
Status:
COMPLETED
Last Update Posted:
2024-02-13
First Post:
2020-07-29
Brief Title:
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
Sponsor:
Direct Biologics LLC
Organization:
Direct Biologics LLC
Organization Data
Organization:
Direct Biologics LLC
Class:
INDUSTRY
Study ID:
DB-EF-PHASEII-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Direct Biologics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None